Elisabeth Schorb

11PUBLICATIONS
72CO-AUTHORS
Haematological tumoursMolecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Apr 16, 2026
Mapping risk and therapy in secondary CNS lymphoma.

|Mar 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Feb 13, 2026
The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous System.

Julia Wendler, Benjamin Kasenda, Eliza M Lauer

|Jan 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Dec 11, 2025
Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma.

Lisa K Isbell, Annika Vreden, Gabriele Ihorst

Pageof 2

Frequent Collaborators

2 joint publications

Eliza M Lauer

2 joint publications

Thais Murciano-Carillo

2 joint publications

Christian Koenecke

2 joint publications

Bertrand Pourroy